INTOXICATION OF HIGH-AFFINITY IL-2 RECEPTOR POSITIVE THYMOCYTES BLOCKS EARLY STAGES OF T-CELL MATURATION

被引:5
|
作者
MASLINSKI, W
MURPHY, JR
STROM, TB
机构
[1] BETH ISRAEL HOSP, DEPT MED, 330 BROOKLINE AVE, BOSTON, MA 02215 USA
[2] HARVARD UNIV, SCH MED, BOSTON, MA 02115 USA
关键词
CYTOKINES; DIPHTHERIA TOXIN FUSION PROTEIN; INTERLEUKINS; T-CELL DEVELOPMENT;
D O I
10.1093/intimm/4.4.509
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Early murine fetal thymocytes express functional, high affinity IL-2 receptors as determined by: (i) the presence of IL-2R beta-chain (p75) mRNA; (ii) IL-2 (10 U/ml) induced cell proliferation/cellular maturation in lobe submersion cultures (LSC). Under the influence of IL-2, early thymocytes differentiate in vitro into more mature, early single positive CD4-CD8+ followed in vivo by double Positive CD4+CD8+ and single positive CD4+CD8-T and CD4-CD8+ thymocytes. Specific intoxication of high affinity IL-2R Positive thymocytes by recombinant interleukin-2-diphtheria toxin-related fusion protein (DAB486-IL-2) results in transient, dose dependent blockade of in vivo and in vitro thymocyte maturation. DAB486-IL-2 induced effects upon in vivo maturation are reversible within 2 weeks after cessation of drug administration. Taken together, these results demonstrate the expression of functional, high affinity IL-2 receptors on early thymocytes. Elimination of high affinity IL-2 receptor positive thymocytes with DAB486-IL-2 results in transient blockade of T cell maturation. Since DAB486-IL-2 is now in clinical trial, it is reassuring to note that it does not permanently disrupt thymic maturation.
引用
收藏
页码:509 / 517
页数:9
相关论文
共 50 条
  • [21] PUTATIVE GAMMA-SUBUNIT OF THE IL-2 RECEPTOR IS DETECTED IN LOW, INTERMEDIATE, AND HIGH-AFFINITY IL-2 RECEPTOR-BEARING CELLS
    COLAMONICI, OR
    NECKERS, LM
    ROSOLEN, A
    JOURNAL OF IMMUNOLOGY, 1990, 145 (01): : 155 - 160
  • [22] TUNICAMYCIN INHIBITS FUNCTION AND EXPRESSION OF THE HIGH-AFFINITY IL-2 RECEPTOR IN A MURINE IL-2-DEPENDENT CELL-LINE
    SEMMES, OJ
    SZTEIN, MS
    BAILEY, JM
    MERRITT, WD
    INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1992, 14 (04): : 583 - 593
  • [23] ROLE OF IL-2 AND IL-4 IN T-CELL ACTIVATION - SPECIFIC CONTROL OF IL-2 RECEPTOR EXPRESSION BY IL-2
    JANKOVIC, DL
    GIBERT, M
    BARAN, D
    THEZE, J
    LYMPHOKINE RESEARCH, 1988, 7 (03): : 316 - 316
  • [24] INDUCTION OF HIGH-AFFINITY PAF RECEPTOR EXPRESSION DURING T-CELL ACTIVATION
    CALABRESSE, C
    NGUER, MC
    PELLEGRINI, O
    BENVENISTE, J
    RICHARD, Y
    THOMAS, Y
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1992, 22 (06) : 1349 - 1355
  • [25] Rational development of high-affinity T-cell receptor-like antibodies
    Stewart-Jones, Guillaume
    Wadle, Andreas
    Hombach, Anja
    Shenderov, Eugene
    Held, Gerhard
    Fischer, Eliane
    Kleber, Sascha
    Stenner-Liewen, Frank
    Bauer, Stefan
    McMichael, Andrew
    Knuth, Alexander
    Abken, Hinrich
    Hombach, Andreas A.
    Cerundolo, Vincenzo
    Jones, E. Yvonne
    Renner, Christoph
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (14) : 5784 - 5788
  • [26] THE 2-CHAIN STRUCTURE OF HIGH-AFFINITY IL-2 RECEPTORS
    SMITH, KA
    IMMUNOLOGY TODAY, 1987, 8 (01): : 11 - 13
  • [27] LIGAND-BINDING IRREVERSIBLY INITIATES INTERNALIZATION OF IL-2 BY HIGH-AFFINITY IL-2 RECEPTORS
    DEPPER, JM
    BERGMAN, A
    DUGAN, E
    CLINICAL RESEARCH, 1987, 35 (06): : A894 - A894
  • [28] MODULATION OF THE T-CELL IL-2 RECEPTOR BY B-ENDORPHIN
    KLEINHENZ, ME
    KILROY, TE
    JOURNAL OF LEUKOCYTE BIOLOGY, 1985, 38 (01) : 129 - 129
  • [29] COMBINATION IL-2 AND IL-4 REDUCES GLUCOCORTICOID RECEPTOR-BINDING AFFINITY AND T-CELL RESPONSE TO GLUCOCORTICOIDS
    KAM, JC
    SZEFLER, SJ
    SURS, W
    SHER, ER
    LEUNG, DYM
    JOURNAL OF IMMUNOLOGY, 1993, 151 (07): : 3460 - 3466
  • [30] STAGES OF T-CELL ACTIVATION - CONTINUED ANTIGEN DEPENDENCE OF IL 2-PRODUCING CELLS AFTER IL-2 RECEPTOR EXPRESSION
    MILLER, RA
    ROZANS, MK
    YTHIER, AA
    STROM, TB
    JOURNAL OF IMMUNOLOGY, 1986, 136 (03): : 977 - 983